| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | 17-AAG |
|---|
| Description | A semi-synthetic derivative of Geldanamycin (Cat. No. 1564-1,5) that displays greater stability and lower in vivo toxicity compared to Geldanamycin. Binds to Heat shock protein 90 (Hsp90) (EC50 = 7.2 μM) in a manner similar to geldanamycin. Exhibits 100-fold higher affinity for tumor-derived Hsp90 over normal cells. Also inhibits Akt activation and HER2 expression in tumor cells. MW: 585.69. Purity ≥98% by HPLC |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Telatinib; 17-(Allylamino)-17-demethoxygeldanamycin; 17-(Allylamino)geldanamycin; Tanespimycin |
|---|
| Gene, Accession, CAS # | CAS: 75747-14-7 |
|---|
| Catalog # | 1774-50 |
|---|
| Price | |
|---|
| Order / More Info | 17-AAG from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|